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repeated injections (100 mg/kg every 48 hr), no protective effect Infant and weanling homozygous Gunn rats received different beyond that of phototherapy alone could be ascertained on the doses (10-200 mg/kg) of the flavin mononucleotide ribofl.5'p. In Purkinje cells in the cerebella of the rats.
short term studies, the tests started with one injection of ribofl.5'p., In the skin of the animals, fluorescence was macroscopic all^ which was given sc, ip, or iv, or with anapplication via gastric noticeable after ribofl.5'~. injections. When an effective irradiance gavage, or cutaneous by bathing the infant rats in an aqueous of about 3.0 mW/cm2 and a high flavin dose (100-1100 mdkg) was ribofl.5'p. solution. In long-term studies, ribofl.5'~. was sc injected administered, histologic investigations of the skin in the abdominal every 48 hr (in a few tests, every 24 hr). and back region revealed a reversible inflatIImat0rY reaction with Immediately after the ribofl.5fp. application, the animals were edema and morphologic changes in the epidermal cells that cul-either illuminated with white or special blue fluorescent tubes or minated 12-24 hr after the injection. After a further increase of kept in complete darkness. In the long-term studies, the rats the effective irradiance, tremendous vesicles On paws, ears, and remained continuously-up to 6 wkPunder the same illuminatails were observed in most of the animals 24-72 hr after the flavin tion. injections. The Content of the blisters Was primarily Serous, later ~h , effective irradiance E~~~~ of the daylight tubes (Osram L 20 on, often hemorrhagic. Finally, necrosis developed. W/19) was ~0 . 3 mW/cm2 and of the special blue tubes (WestingAcute toxicity of ribofl.5'~. differed markedly when the infant house F 20 T 12/BB) ~3 . 0 .
the following text the rats (homozygous jaundiced as well as heterozygous nonjaundiced) general term "daylight or special blue" stands for these two were kept in the dark or under intense blue phototherapy. Much higher doses were tolerated in the dark.
These types of fluorescent tubes are the ones most often used in Moreover, it could be demonstrated that ribofl-S'P. does not hospitals. Effective irradiance, 0.3 mw/cm2, comes close to that influence Serum bilirubin of jaundiced Gunn rats kept in complete measured in incubators when phototherapy with a bank of daydi~rkness-That suggests that the drug itself does not compete for light fluorescent tubes is given from above. With fluorescent tubes albumin binding sites. But certain riboflavin ampules (Beflavin) 3.0 m~/ c m 2 can in newborn babies only be by doublecontain stabilizers that considerably displace bilirubin from albu-direction phototherapy special blue lamps. min bonds. Riboflavin disturbs direct photometric bilirubin meashelves, cages, and the special handling of the rats were surements, but not the diazo reaction. When bilirubin is to be described by Ballowitz (1) . In this publication, a detailed measured in sera containing riboflavia* lights must be extremely definition of the spectral efficiency curve, the effective irradiance dim. Photodegradation in vitro is highly accelerated by the semi-E~~~~ and the radiometer used is also given. The peak sensitivity of tizer.
the radiometer is at 460 nm (in the blue region of the spectrum) and half maximum sensitivities are at 435 and 488 nm. Speculation
In the course of the investigations, the indication for higher effective irradiance arose. To attain ~4 . 5 mw/cm2 Philips TL 20 Riboflavin certainly enhances photodegradation of bilirubin. W/52 BAM blue tubes (with 20 input) were selected or But, because the animal tests revealed serious side effects, it Westinghouse 20 12/BB special blue tubes were operated cannot be regarded as a safe adjunct to phototherapy in h m a n with 40 w input. with daylight tubes (osram L 20 ~/ 1 9 ) , an infants.
effective irradiance of ~3 . 2 mW/cm2 could only be attained by diminishing distance between tubes and cages plus 40 W input. On discussing these high illuminations in the second part of the Kostenbauder and Sanvordeker (1 1, 17) pointed out that r i bthe effective irradiance E~~~~ be quoted. flavin enhances photodegradation of bilirubin and might improve the efficiency of phototherapy in hyperbilirubinaemia in new- SERUM BILIRUBIN borns. Preliminary clinical trials seemed to confirm the expected effect (9, 14) . Because flavins must be regarded as active photoBlood was taken from the cut tail of the rats before and in fured sensitizers, the problem of side effects arises. Speck and coworkers intervals after the injections. Direct photometric bilirubin mea- (21, 22) 
CHEMICALS
For the main tests, pure ribofl.5'~. substance (LaRoche) was dissolved under dim lights in sterile distilled water and, immediately thereafter, injected into the animals. For orientation, Beflavin ampules (La Roche) were used in a few experiments. Besides riboflavin, these ampules contain as stabilizers Nipagin/ Nipasol, Na hydrogen phosphate, Na oxy-methoxybenzoate. (The concentration of the different substances was not declared by the manufacturers).
ACUTE TOXICITY
Following the method of Behrens and Karber (3), LDsO of ribofl.5'~. (and of Beflavin) was determined in the dark, under daylighi, o; special blue phototherapy in homozygous (jaundiced) as well as in heterozygous (nonjaundiced) 3-to 5-day-old Gunn rats.
KERNICTERUS GRADING
Histochemical staining of oxidative enzymes LDH, SDH, and NaDHa-Tetrazolium reductase in the Purkinje cells of the cerebellum (2, 8) uncovers the nerve cell loss by bilirubin encephalopathy. These investigations were camed out after repeated injections of ribofl.5'~. or of saline dummy injections in illuminated and nonilluminated animals.
EXAMINATIONS OF THE SKIN
After ribofl.5'~. injections, the degree and duration of fluorescence in the skin was macroscopically noticed and so was the formation of vesicles and areas of necrosis on paws, tails, and ears.
For histologic investigations, skin sections were prepared from the abdominal and back region, and the PAS (periodic acid Schiff) reaction as well as the hematoxylin-eosin stainings were compared. Furthermore, vesicles and areas of necrosis on paws, tails, and ears were examined with the light-and the electronmicroscope.
RESULTS AND DISCUSSION
Only the main data and conclusions will be given. Details can be taken from the theses of Bunjamin (4), Lietz (12) , and Wijadi (23).
SERUM BILIRUBIN
Methodical particularities. In general, serum bilirubin concentration of Gunn rats as well as of human infants can be precisely measured with the American Optical Bilirubinometer. This instrument is designed to indicate the light transmission through the serum specimen at 461 nm-the absorption peak of bilirubinand simultaneously at 55 1 nm. Internal subtraction of the absorption at 551 nm from that at 461 nm offsets the absorption by hemoglobin in moderately hemolytic sera.
Direct photometric bilirubin measurements with the American O~tical Bilirubinometer moved disturbed by riboflavin which has a haximum absorption i t 450 nm. Its absobtion slope obviously comes into the 460 nm region. Figure 1 shows kind of a calibration for ribofl.5'~. on this ins<rurnent.-ema ark able deviations are to be expected with high ribofl.5'~. contents.
With the chemical method on diazo basis, no such disturbances occurred. In vitro addition of ribofl.5'~. to sera of homo-or of heterozygous Gunn rats had no influence on the bilirubin value measured on diazo basis. The same was true when (instead of a fresh ribofl.5'~. solution) the photo-products, which originated during illumination of an aqueous ribofl.5'~. solution in the presence of oxygen in vitro, were added.
For our main investigation, therefore, this method was used. Utmost care was necessary to shield off lights when measuring bilirubin in sera containing riboflavin. In the presence of flavin and light, bilirubin concentration decreased much faster than in solutions containing bilirubin only.
SERUM BILIRUBIN AFTER RIBOFLAVIN APPLICATION IN THE DARK
Ribofl.5'~. does not significantly influence serum bilirubin in complete darkness, neither in vitro nor in vivo. Figure 2b demonstrates the mean serum bilirubin in 3-to 5-day-old rats before, 30 min, 3 hr, and 24 hr after sc injection of 100 or 200 mg/kg ribofl.5'~. Figure 3b gives the same data in 1-month-old rats. From this observation, it may be concluded that ribofl.5'~. itself does not considerably compete with bilirubin for albumin binding sites. Injections of other compounds, which do strongly compete (sulfonamides or benzoates for instance), induce a sharp decline in the serum bilirubin concentration of Gunn rats. The displaced bilirubin equilibrates with other compartments.
Such a decline occurred when, instead of ribofl.5'~. solution, Beflavin ampules were used which contain benzoate stabilizers. Thirty min after sc injection of 2 ml/kg Beflavin (= 10 mg/kg riboflavin) or of 2 ml/kg of the stabilizer alone (LaRoche supplied us with this special preparation, without riboflavin) serum bilirubin in 3-to 5-day-old homozygous Gunn rats dropped to 55-60% of the starting level and remained there for more than 3 hr. Even 24 hr later, the starting level was not reached again. Obviously, the stabilizer displaced bilirubin from the plasma albumin bonds. Figure 2a demonstrates the effect of daylight and special blue phototherapy alone-without flavin injections-in 3-to 5-day-old rats, and Figure 3a the same in I-month-old rats.
SERUM BILIRUBIN AFTER PHOTOTHERAPY
These and the following diagrams represent the mean results of serial measurements of serum bilirubin concentrations. The starting level is taken as 100 and the levels obtained during the illumination are expressed in percent of this starting level. SD are not marked on the curves for graphical reasons and because of the A Serum bilirubin curves in 3-to 5-day old homozygous Gunn rats in the dark, or under daylight (Eh,l, 0.3 mW/cm2), or special blue (Ehil, 3.0 mw/cm2) phototherapy without any injections. B-E Changes of the mean serum bilirubin concentration in 3-to 5-day old homozygous Gunn rats after S.C. ribofl.5'~. injections B) animals kept in practically complete darkness, C ) animals kept under daylight illumination; Ehili 0.3 mW/cm2, D) animals kept under special blue illumination. Ehil, 3.0 mW/cm2 E ) animals kept under BAM blue illumination Ehi~, 4.5 mW/cm2. small numbers in some animal groups. Table I gives the appro-5-9%. In all groups of animals that were injected with ribofl.5'p., priate data in mg/dl for Figures 2a and 3a .
the 30 min and 3 hr values differed from the starting level with Proceeding from each single animal, analyses of SD and SEM the same trend; i.e., a serum bilirubin decline. This allows to use were done on the percent basis. In all groups, SEM of the the one-tailed t-test, and a 30 min difference in the curves of 6-8% difference in serum bilirubin between start and 30 min revealed and a 3 hr difference of 1&14% can be regarded as significant (P 3-4%, between start and 3 hr, 5-7%, and between start and 24 hr, < 0.05). Compared to 3-to 5-day-old rats (without fur), the serum bilirubin decline by phototherapy alone is steeper in I-month-old rats (special blue 3 hr, P < 0.05, 24 hr, P < 0.01, daylight 24 hr, P c 0.01) despite the fact that the older rats have a fairly thick fur, and hair must be regarded as a light trap. This can only be explained by the fact that bilirubin metabolism is in a steady state in-I-month-old rats, whereas in the infant rats, it is not so. serum bilirubin of 3-to 5-day-old rats physiologically rises. In light-exposed animals receiving riboJ.5'p.. serum bilirubin decreases not only in relation to the injected ribofl.5'~. dose, but also to the amount of effective irradiance applied. The flavin effect is significantly more marked in infant than in I-month-old rats.
INFLUENCE OF ONE SINGLE RIBOFL.5'P. DOSE ON THE PHOTOTHERAPY EFFECT
In Figure 2c , the 30 min and 3 hr difference in serum bilirubin concentration between the four doses used is greater than IWO (P In Figure 2c -e, mean serum bilirubin of 3-to 5-day-old rats < 0.05). The same is true for three of the four curves in Figure 2d receiving different doses of ribofl.5'~. sc under different irradiance and for 2 of the 3 curves in Figure 2e . Taking 100 mg ribofl.5'~. as a basis, it is easy to recognize that the different enhancement of bilirubin decline by the three types of lamps distinctly surpasses 10% (P < 0.05).
In contrast to Kostenbauder and Sanvordeker (I I), enhancement of bilirubin photo-decay by injected ribofl.5'~. under white as well as under special blue lights was observed in this study. These authors used shaved adult Gunn rats for their experiments and only saw an effect of the flavin in combination with daylight phototherapy of low effective irradiance (300 foot candles), but not when 75&1100 foot candles were applied. In the latter group, serum bilirubin rapidly declined with phototherapy alone.
With the exception of the low ribofl.5'~. doses under daylight the deepest fall in serum bilirubin concentration in 3-to 5-day-old rats (Figs. 2c-e) was measured 3 hr after the sc injection. Twentyfour hr after the injections, serum bilirubin under daylight is in the same range as with phototherapy alone, and it is almost so with special blue. Only after 50 or 100 mg/kg ribofl.5'~. sc and 24 hr BAM blue illumination (Ebili 4.5 mW/cm2) is the serum bilirubin concentration in infant rats still markedly lower than with
KERNICTERUS GRADING
Histochemical staining of the Purkinje cells in the cerebellum was carried out after repeated sc injections of 100 mg/kg ribofl.5'~. or dummy injections and different illumination. Bilirubin inhibits the activity of oxidative and glycolytic enzymes. Affected Purkinje cells do not show up any more in the sections (8).
The results of the long-term studies with 13-28 injections are summarized in Table 2 (No blood for bilirubin measuring was taken from these rats).
A significant difference between ribofl.5'p.-injected and control rats (with saline dummy injections) could not be ascertained either in the animals kept in the dark or in the illuminated groups. It was obvious that special blue light illumination provided a pronounced protection, so that probably no further improvement by the ribofl.5'~. photosensitisation was possible. However, even in the animals receiving low intensity phototherapy with daylight tubes, the loss of Purkinje cells was not significantly reduced by ribofl.5'~.
BAM blue vhototheravv alone.
FLUORESCENCE OF THE SKIN AND THE URINE
The ov&all enhakement of phototherapy by sc injected ribofl.5'~. is distinctly lower in I-month-old rats. The early decline is comparably small (Figs. 3c and d) . From other comparisons between these two age groups of rats (Goebel) , it can be assumed that this is due mainly to delayed equilibration of ribofl.5'~. between skin and blood in the older ones.
Half Ife of ribofl.5). in the blood of the rats is short. Christensen (5) indicates 12 min. as t/2 of the disappearance rate and 26 min. as t/2 of urinary excretion. This may explain that between 3 and 24 hr after the injection, serum bilirubin concentration in infant rats increases again, even when phototherapy is continued. It is here where our results differ from studies on photosensitized Gunn rats reported by McDonagh (13) using hematoporphyrin as a sensitizer instead of riboflavin. In his experiments, the pronounced drop in serum bilirubin induced by porphyrin plus light continued up to 24 hr even when the lights were turned off 6 hr after the porphyrin injection. Half-life time of hematoporphyrin is long and in contrast to riboflavin, porphyrins become concentrated in the basal layers of the dermis (15). In the skin of human beings, hematoporphyrin is demonstrable for at least 4 wk after one iv injection (10).
Serum bilirubin decline after ip and iv injection of ribofl.5). was not very different from that seen after sc injections. In infant rats, the initial slope turned out somewhat steeper, so that the lowest value was already reached 30 min after-ip or iv application, followed by a plateau or a slight increase between 30 min and 3 hr. The 3-hr levels were nearly equal after sc, ip, or iv injection. Serum bilirubin of I-month-old rats illuminated with special blue tubes also showed a somewhat more pronounced decline after ip than after sc application, but the difference was not statistically significant.
The authors were unable to demonstrate any effect of ribofl.5'~. on the serum bilirubin concentration in illuminated infant rats after oral (up to 2000 mg/kg) or cutaneous application of an aqueous solution of the flavin.
SERUM BILIRUBIN IN LONG-TERM STUDIES
In long-term studies, 100 mg/kg ribofl.5'~. or saline dummy injections were sc administered every 48 hr. Serum bilirubin concentration was determined before every 2nd injection. At that time, there was probably no more ribofl.5'~. left in the animal. The results are given in Figure 4 . Under special blue lights, no difference could be ascertained between ribofl.5'~. injected animals and the control group. Under white lights and in the dark (In this experimental series, some room lighting reached the animals during handling and blood sampling), the riboflavintreated group showed lower serum bilirubin between days 9-25 than the saline-treated group. The difference is about 2 mg/dl in the 3rd wk and diminishing thereafter with increasing age parallel to the development of the fur and the physiologic bilirubin decline.
About 5-10 rnin after sc injection of ribofl.5'~. into infant rats, fluorescence, which initially appears around the site of the injection, is already macroscopically noticeable on the whole body of the animal (We did not carry through special measurements of the excitement). After a sc dose of 200-mg]kg, it lasts under special blue illumination for about 3-4 hr. after iv or iv iniection. about 2-3 hr. Under daylight, it can be seen f& about (-7 hr after sc and up to 6 hr after iv or ip application.
In 1-month-old rats, fluorescence is less impressive. Immediately after iv injection, the phenomenon was perceived on the hairless ears, the paws, and the snout. The peak was between 10 and 30 min, and it disappeared by I to 1% hr. There was no great difference under special blue or daylight. The first color change after sc injection could only be seen after 20 min. It was distinctly less pronounced than after iv injection. . Changes in the mean serum bilirubin concentration during long-term studies in homozygous Gunn rats receiving ribofl.5'~. or saline dummy s.c. injections every 48 hr. (In these long-term studies some lights reached the animals in the dark during handling). Each group covered 4 animals at the start (during the 3rd wk two ribofl.5'~. injected rats died under special blue, and two in both groups in the dark. SD did not exceed 7.2 mg/dl).
A yellowish color and fluorescence was noticeable in the urine about 3-5 min after iv or ip injection, and about 10 min after sc injection of 200 mg/kg. The excretion lasted for more than 10 hr in infant as well as in I-month-old rats.
HISTOLOGIC INVESTIGATIONS OF THE SKIN FROM THE ABDOMINAL AND BACK REGlON
Periodic acid-Schiff (PAS) and hematoxylin-eosin stainings of skin sections from the abdominal and back region were carried Table 2 . Kernic out only after sc injections with daylight, special blue, or no illumination at all. Only when under special blue illumination, a high dose (100-200 mg/kg) ribofl.S1p. was given, a reversible phototoxic reaction revealed with edema and morphologic changes in the epidermal cells, i.e., positive intracellular PAS reactions, a tendency to pyknosis of the nuclei and blurred contours of the cells. No equivalents could be seen in animals receiving the same ribofl.5'~. dose, but being kept in the dark or under daylight phototherapy. The skin lesions under special blue lights were found in homozygous jaundiced animals as well as in het- erozygous nonjaundiced rats. The inflammatory reactions culminated between 12 and 24 hr after the injection.
When under continuous special blue illumination, 10-20 injections of 100 mg/kg were administered in intervals of 48 hr, no skin reactions could be demonstrated in the abdominal or back region of the animals. At the time of the investigation, the rats were I-month-old or older and had a thick fur. In 2 of 10 animals, which repeatedly received 100 mg/kg under special blue lights, vesicles and areas of necrosis appeared on the paws and the tail. Morphology of the alterations could be regarded as typical for phototoxic reactions in rodents (24) . This last observation induced-as mentioned previously-the additional tests with the rather high irradiance of 3.24.5 mW/cm2.
PHOTOTOXIC REACTIONS ON PAWS. TAILS. AND EARS
When an effective irradiance of more than 3 mW/cm2 was employed and as an adjunct 100-200 mg/kg ribofl.5'~. sc characteristic lesions appeared in high frequency on the acra. Details are listed in Table 3 . The vesicles developed 1 4 days after the ribofl.5'~. injections under continuous illumination. They equally appeared in homozygous and in heterozygous infant rats. Many of the animals receiving 200 mg/kg ribofl.5'~. sc died within a few hr becoming adynamic, hypotonic, and anuric (the few drops of urine which still could be emptied were intensely yellowishfluorescent). These animals did not (yet) show skin lesions. No such reactions on the acra occurred in animals kept under the same lights but receiving dummy injections. There w&e no striking differences between the different tubes used. Obviously, the high amount of effective irradiance turned the scale. ~i~u i e 5a-c &e photographs of particularly severe lesions. In general, the content of the vesicles on paws and tails was initially serous. In those animals, which received a second ribofl.5'~. dose 48 hr after the first one, the liquid in the vesicles got intensely yellowish and more fluorescent than the surrounding skin a few min after the second application. Especially at the ears, the vesicles soon became hemorrhagic. Four to six days after appearing, the blisters dried up, leaving parts of the toes, of the ears, and of the tails necrotic (Fig. 6) . The general condition of the animals had to be marked as bad. All these rats were killed.
HISTOLOGIC INVESTIGATIONS OF THE BLISTERS
Serial sections mainly from tails were investigated. Unlike paws, the tails needed no bone-decalcification. Figure 7b+c represent the typical features. Probably as a result of permeability changes in the blood vessels, massive perivascular edema were developing. Increased interstitial fluid that pressed against the epidermis formed blisters in the subepidermal space lifting the epidermis from the corium. Stratum basale cells appeared swollen and acantholytic. Morphologically, it was impossible to decide. whether an additional loosening of the epidermis-caused by phototoxic substances-had occurred. As for the necrotic parts, vasculitis and fibrinoid necrosis could clearly be recognized (Fig.  8) .
MORTALITY (LD50)
In homozygous as well as in heterozygous infant Gunn rats, acute toxicity of ribofl.5'~. differed markedly when the animals were kept uhder intense'blue phototherapy .or remained in the dark. Under special blue lights 70-90% of heterozygous infant rats receiving 200 mg/kg ribofl.5'~. sc died within I 4 days, whereas 600 mg/kg were tolerated by all animals kept in the dark or under daylight illumination with an effective irradiance of 0.3 mW/cm2. Fifty% of the 3-to 5-day-old rats in the dark or under this low irradiance daylight phototherapy survived 800-900 mg/kg. Acute toxicity of Beflavin ampules was about 1 0 times higher. It was clearly demonstrated that this was caused by the stabilizer added.
C O N C L U S I O N S
In all probability, comparably large doses of riboflavin will likewise be needed in newborn babies to achieve considerable speeding up of bilirubin photodegradation. In long-term studies in the rats, riboflavin plus phototherapy with low effective irradiance did not reach the effect of an intense blue phototherapy without adjunct. When high flavin doses and a high effective irradiance are applied, side effects on the skin must also be expected in human beings. Moreover, the increased mortality of Fig. 7 . A Hematoxylin eosin stain of the normal tail of a control animal rats under intensive phototherapy as compared to those kept in the dark, points to more general disturbances arising from phototoxic or photodynamic reactions. This may correspond with the above cited observations of Speck et al. (21) and Santella et al. (16) , who demonstrated that photoactivated riboflavin will change the structure of DNA.
Several authors (Sisson et al. (19, 20) and Gromisch et a[. (7), reported on riboflavin deficiency in neonates being provoked by phototherapy. Their results are in accordance with our animal experiments. However, the amount of riboflavin involved is small and likely to be of no major concern. If riboflavin-substitution is considered, it should be administered after phototherapy has been completed and under the exclusion of ampules containing stabilizers.
